Ridgway, H., Apostolopoulos, V., Moore, G. J., Gadanec, L. K., Zulli, A., Swiderski, J., . . . Matsoukas, J. M. Computational Evidence for Bisartan Arginine Blockers as Next-Generation Pan-Antiviral Therapeutics Targeting SARS-CoV-2, Influenza, and Respiratory Syncytial Viruses. MDPI AG.
Chicago Style (17th ed.) CitationRidgway, Harry, et al. Computational Evidence for Bisartan Arginine Blockers as Next-Generation Pan-Antiviral Therapeutics Targeting SARS-CoV-2, Influenza, and Respiratory Syncytial Viruses. MDPI AG.
MLA (9th ed.) CitationRidgway, Harry, et al. Computational Evidence for Bisartan Arginine Blockers as Next-Generation Pan-Antiviral Therapeutics Targeting SARS-CoV-2, Influenza, and Respiratory Syncytial Viruses. MDPI AG.
Warning: These citations may not always be 100% accurate.